Search for other papers by Victor Jing-Wei Kang in
Google Scholar
PubMed
Search for other papers by Bo-Ching Lee in
Google Scholar
PubMed
Search for other papers by Jia-Zheng Huang in
Google Scholar
PubMed
Search for other papers by Vin-Cent Wu in
Google Scholar
PubMed
Search for other papers by Yen-Hung Lin in
Google Scholar
PubMed
Search for other papers by Chin-Chen Chang in
Google Scholar
PubMed
Search for other papers by TAIPAI group in
Google Scholar
PubMed
phosphate, had higher serum levels of PAC, ARR, creatinine, 24-h urine calcium and intact parathyroid hormone (iPTH), more frequently used hypertensive medication, and more frequently had renal or ureteral stones (47, 26.3% vs 16, 12.0%; P = 0.002) than
Search for other papers by Debra M Gordon in
Google Scholar
PubMed
Search for other papers by Pablo Beckers in
Google Scholar
PubMed
Search for other papers by Emilie Castermans in
Google Scholar
PubMed
Search for other papers by Sebastian J C M M Neggers in
Google Scholar
PubMed
Search for other papers by Liliya Rostomyan in
Google Scholar
PubMed
Search for other papers by Vincent Bours in
Google Scholar
PubMed
Search for other papers by Patrick Petrossians in
Google Scholar
PubMed
Search for other papers by Vinciane Dideberg in
Google Scholar
PubMed
Search for other papers by Albert Beckers in
Google Scholar
PubMed
Search for other papers by Adrian F Daly in
Google Scholar
PubMed
particularly true in the case of pheochromocytomas and paragangliomas (PPGL) ( 1 ). These neuroendocrine tumors produce symptoms due to direct tumor effects and the synthesis and release of bioactive amines, neurotransmitters, and hormones; about 20 new